Skip to content
Bored Studies
RecruitingPhase 2

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

InventisBio Co., Ltd · NCT07489885

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–70 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 2
Target enrollment
75
US sites recruiting
3
Study start
June 3, 2026
Record last updated
July 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis

Being studied: D-2570 Tablet; Placebo Tablets

Conditions: Psoriasis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Participants with a diagnosis of plaque psoriasis with no significant flares of disease activity for at least 6 months before signing the informed consent
  • Participants have moderate to severe plaque psoriasis as defined by a total body surface area (BSA) ≥10%, a Psoriasis Area and Severity Index (PASI) score ≥ 12 and a Physician's Global Assessment (PGA) score ≥ 3.
  • Within normal ranges of laboratory assessments

Exclusion Criteria

  • Any comorbidities or past medical conditions as outlined in the protocol that would interfere with study assessments as deemed by the Investigator

Recruiting US locations

  • Study Center

    Birmingham, AL 35244

    Site contact: Kathryn Stazzone · 302-519-5966 · kathryn.stazzone@inventisbio.com

  • Study Center

    Chula Vista, CA 91910

    Site contact: Kathryn Stazzone · 302-519-5966 · kathryn.stazzone@inventisbio.com

  • Study Center

    San Antonio, TX 78218

    Site contact: Kathryn Stazzone · 302-519-5966 · kathryn.stazzone@inventisbio.com

Study contacts (from the official record)

  • Kathryn Stazzone · 3025195966 · kathryn.stazzone@inventisbio.com
All dermatology studies in Alabama →
A Study to Evaluate D-2570 in Participants With Moderate to Severe… (NCT07489885) | Bored Studies